Skip to search.
 TSX Down 0.94% TSX Ventures Down 3.46%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
5.62 Down 0.37(6.18%) Aug 24, 4:00PM EDT
Prev Close:5.99
Open:5.97
Bid:5.00 x 1000
Ask:6.10 x 2900
1y Target Est:9.25
Beta:1.11314
Earnings Date:Nov 2 - Nov 7 (Est.)
Day's Range:5.60 - 6.05
52wk Range:4.14 - 7.74
Volume:946,465
Avg Vol (3m):800,752
Market Cap:445.18M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SPPIDown 6.18%445.18M
BIIBDown 2.78%67.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.62
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-16) :-1.11
Quarterly EPS Est (Sep-16) :-0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback